Short-term side effects during H. pylori eradication therapy

Acta Gastro-Enterologica Belgica

Volumn 61, Issue 3, 1998, Pages 348-349

  Dumonceau, J M ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Adverse events; Helicobacter pylori; Side effects; Treatment

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BISMUTH DERIVATIVE; CARBAMAZEPINE; CLARITHROMYCIN; ERYTHROMYCIN; LITHIUM; METRONIDAZOLE; NITROIMIDAZOLE DERIVATIVE; OMEPRAZOLE; ORAL CONTRACEPTIVE AGENT; PHENYTOIN; PROTON PUMP INHIBITOR; TETRACYCLINE DERIVATIVE; THEOPHYLLINE; WARFARIN;

BLOOD TOXICITY; CONFERENCE PAPER; DRUG ALCOHOL INTERACTION; FATIGUE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL INFECTION; GASTROINTESTINAL SYMPTOM; HELICOBACTER PYLORI; HUMAN; INFECTION; LIVER TOXICITY; NEPHROTOXICITY; NEUROTOXICITY; OTOTOXICITY; VERTIGO;

ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CLINICAL TRIALS; DRUG THERAPY, COMBINATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PROTON PUMPS; TIME FACTORS;

EID: 0031693845     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (11)

1. SMALLWOOD R.A., BERLIN R G., CASTAGNOLI N., FESTEN H.P M., HAWKEY C J., LAM S.K , LANGMAN M.J.S., LUNDBORG P., PARKINSON A. Safety of acid-suppressing drugs. Digestive Diseases and Sciences, 1995, 40 (Suppl.) . 63S-80S.
2. MEYER U.A. Metabolic interactions of the proton-pump inhibitors lansoprazole. omeprazole and pantoprazole with other drugs. European Journal of Gastroenterology & Hepatology, 1996, 8 (Suppl.) : S21-S25.
3. TILLMAN L A , DRAKE F.M., DIXON J.S., WOOD J.R. Review article : safety of bismuth in the treatment of gastrointestinal diseases. Aliment Pharmacol. Ther., 1996, 10 : 459-467
4. PLAYFORD R.J., MATTHEWS C.H., CAMPBELL M J., DELVES H.T., HLA K.K., HODGSON H.J., CALAM J. Bismuth induced encephalopathy caused by tri potassium dicitrato bismuthate in a patient with chronic renal failure. Gut. 1990, 31 359-60.
5. THOMSON G., CLARK A.H . HARE K., SPILG W.G.S. Pseudomembranous colitis after treatment with metronidazole. British Medical Journal, 1981, 282 : 884-885.
6. NAHATA M. Drug interactions with azithromycin and the macrolides : an overview. Journal of Antimicrobial Chemotherapy, 1996, 37 (Suppl.). 133S-142S.
7. LAU A.H., LAM N.P., PISCITELLI S.C, WILKES L., DANZIGER L H. Clinical pharmatokinetics of metronidazole and other nitroimidazole anti-infectives. Clinical Pharmatokinetics, 1992, 23 : 328-364
8. SCHENTAG J.J., ZIEMNIAD J.A., GRECO J.M., RAINSTEIN M., BUCKLEY R J. Mental confusion in a patient treated with metronidazole - concentration related effect ? Pharmacotherapy, 1982, 2 . 384-387
9. PENSTON AND MCCALL Eradication of Helicobacter pylori . an objective assessment of current therapies. British Journal Clinical Pharmacology, 1997, 43 : 223-243.
10. PETERSON V.V.L., CIOCIOLA A.A., SYKES D.L., MCSORLEY D.J., WEB D.D. & THE RBC 11. PYLORI STUDY GROUP. Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylon and reducing ulcer recurrence. Aliment. Pharmacol. Ther., 1996, 10 . 251-261.
11. POUNDER R.E., BAILEY R., LOUW J.A., OHLIN B., DIXON M F, QUIRKE P., DUGGAN A E. GR122311X (ranitidine bismuth citrate) with clarithromycin for the eradication of Helicobacter pylon. Gastroenterology. 1996, A166